Literature DB >> 31067074

Proton therapy for brain tumours in the area of evidence-based medicine.

Damien C Weber1,2,3, Pei S Lim1, Sebastien Tran1, Marc Walser1, Alessandra Bolsi1, Ulrike Kliebsch1, Jürgen Beer1, Barbara Bachtiary1, Tony Lomax1,4, Alessia Pica1.   

Abstract

ADVANCES IN KNOWLEDGE: This review details the indication of brain tumors for proton therapy and give a list of the open prospective trials for these challenging tumors.

Entities:  

Mesh：

Year:  2019        PMID： 31067074      PMCID： PMC7066950          DOI： 10.1259/bjr.20190237

Source DB:  PubMed          Journal:  Br J Radiol        ISSN： 0007-1285            Impact factor:   3.039


  115 in total

1.  Tumor control and QoL outcomes of very young children with atypical teratoid/rhabdoid tumor treated with focal only chemo-radiation therapy using pencil beam scanning proton therapy.

Authors:  Damien C Weber; Carmen Ares; Robert Malyapa; Francesca Albertini; Gabriele Calaminus; Ulrike Kliebsch; Lorentzos Mikroutsikos; Petra Morach; Alessandra Bolsi; Tony Lomax; Ralf Schneider
Journal:  J Neurooncol       Date:  2014-11-02       Impact factor: 4.130

2.  Imaging Changes in Pediatric Intracranial Ependymoma Patients Treated With Proton Beam Radiation Therapy Compared to Intensity Modulated Radiation Therapy.

Authors:  Jillian R Gunther; Mariko Sato; Murali Chintagumpala; Leena Ketonen; Jeremy Y Jones; Pamela K Allen; Arnold C Paulino; M Fatih Okcu; Jack M Su; Jeffrey Weinberg; Nicholas S Boehling; Soumen Khatua; Adekunle Adesina; Robert Dauser; William E Whitehead; Anita Mahajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2015-05-16       Impact factor: 7.038

3.  Outcomes and acute toxicities of proton therapy for pediatric atypical teratoid/rhabdoid tumor of the central nervous system.

Authors:  Susan L McGovern; M Fatih Okcu; Mark F Munsell; Nancy Kumbalasseriyil; David R Grosshans; Mary F McAleer; Murali Chintagumpala; Soumen Khatua; Anita Mahajan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-10-11       Impact factor: 7.038

4.  Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up.

Authors:  Linda Douw; Martin Klein; Selene Saa Fagel; Josje van den Heuvel; Martin Jb Taphoorn; Neil K Aaronson; Tjeerd J Postma; W Peter Vandertop; Jacob J Mooij; Rudolf H Boerman; Guus N Beute; Jasper D Sluimer; Ben J Slotman; Jaap C Reijneveld; Jan J Heimans
Journal:  Lancet Neurol       Date:  2009-08-07       Impact factor: 44.182

5.  Reoptimization of Intensity Modulated Proton Therapy Plans Based on Linear Energy Transfer.

Authors:  Jan Unkelbach; Pablo Botas; Drosoula Giantsoudi; Bram L Gorissen; Harald Paganetti
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-09-01       Impact factor: 7.038

6.  Proton stereotactic radiosurgery for the treatment of benign meningiomas.

Authors:  Lia M Halasz; Marc R Bussière; Elizabeth R Dennis; Andrzej Niemierko; Paul H Chapman; Jay S Loeffler; Helen A Shih
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-10-08       Impact factor: 7.038

7.  Cost effectiveness of proton therapy compared with photon therapy in the management of pediatric medulloblastoma.

Authors:  Raymond B Mailhot Vega; Jane Kim; Marc Bussière; Jona Hattangadi; Abby Hollander; Jeff Michalski; Nancy J Tarbell; Torunn Yock; Shannon M MacDonald
Journal:  Cancer       Date:  2013-09-16       Impact factor: 6.860

Review 8.  "Radiobiology of Proton Therapy": Results of an international expert workshop.

Authors:  Armin Lühr; Cläre von Neubeck; Jörg Pawelke; Annekatrin Seidlitz; Claudia Peitzsch; Søren M Bentzen; Thomas Bortfeld; Jürgen Debus; Eric Deutsch; Johannes A Langendijk; Jay S Loeffler; Radhe Mohan; Michael Scholz; Brita S Sørensen; Damien C Weber; Michael Baumann; Mechthild Krause
Journal:  Radiother Oncol       Date:  2018-06-01       Impact factor: 6.280

9.  Treatment outcomes of proton or carbon ion therapy for skull base chordoma: a retrospective study.

Authors:  Masaru Takagi; Yusuke Demizu; Fumiko Nagano; Kazuki Terashima; Osamu Fujii; Dongcun Jin; Masayuki Mima; Yasue Niwa; Kuniaki Katsui; Masaki Suga; Tomohiro Yamashita; Takashi Akagi; Koh-Ichi Sakata; Nobukazu Fuwa; Tomoaki Okimoto
Journal:  Radiat Oncol       Date:  2018-11-26       Impact factor: 3.481

10.  Dosimetric Comparison of Proton Radiation Therapy, Volumetric Modulated Arc Therapy, and Three-Dimensional Conformal Radiotherapy Based on Intracranial Tumor Location.

Authors:  Sebastian Adeberg; Semi B Harrabi; Nina Bougatf; Vivek Verma; Paul Windisch; Denise Bernhardt; Stephanie E Combs; Klaus Herfarth; Juergen Debus; Stefan Rieken
Journal:  Cancers (Basel)       Date:  2018-10-26       Impact factor: 6.639
View more
  5 in total

1.  Proton therapy special feature: introductory editorial.

Authors:  Kathryn D Held; Antony J Lomax; Esther G C Troost
Journal:  Br J Radiol       Date:  2020-03       Impact factor: 3.039

2.  Treatment plan comparison of proton vs photon radiotherapy for lower-grade gliomas.

Authors:  Camilla S Byskov; Christian R Hansen; Rikke H Dahlrot; Lene Haldbo-Classen; Charlotte A Haslund; Flemming Kjær-Kristoffersen; Thomas O Kristensen; Yasmin Lassen-Ramshad; Slávka Lukacova; Aida Muhic; Petra W Nyström; Britta Weber; Jesper F Kallehauge
Journal:  Phys Imaging Radiat Oncol       Date:  2021-11-28

3.  Integrating Nanotechnology in Neurosurgery, Neuroradiology, and Neuro-Oncology Practice-The Clinicians' Perspective.

Authors:  Fred C Lam; Fateme Salehi; Ekkehard M Kasper
Journal:  Front Bioeng Biotechnol       Date:  2022-02-09

4.  Prediction Models for Radiation-Induced Neurocognitive Decline in Adult Patients With Primary or Secondary Brain Tumors: A Systematic Review.

Authors:  Fariba Tohidinezhad; Dario Di Perri; Catharina M L Zegers; Jeanette Dijkstra; Monique Anten; Andre Dekker; Wouter Van Elmpt; Daniëlle B P Eekers; Alberto Traverso
Journal:  Front Psychol       Date:  2022-03-31

Review 5.  Particle therapy in Europe.

Authors:  Cai Grau; Marco Durante; Dietmar Georg; Johannes A Langendijk; Damien C Weber
Journal:  Mol Oncol       Date:  2020-04-22       Impact factor: 7.449
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.